Vall d'Hebron Institute of Research, Galatea Clinic Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3 Phase 4
Founded: Barcelona Spain (1994)

Organization Overview

First Clinical Trial
First Marketed Drug
First NDA Approval
Last Known Activity


  • Now

Alternative names

David Garcia-Dorado | Department of HPB Surgery and Transplants, Hospital Universitario Vall d´Hebron | Department of Oncology, Hospital Universitario Vall d´Hebron | Francesc Bosch, MD | Hospital Universitario Vall d´Hebron | HOSPITAL UNIVERSITARIO VALL D´HEBRON, UNIVERSIDAD AUTONOMA, BARCELONA | HOSPITAL UNIVERSITARIO VALL D´HEBRON, UNIVERSIDAD AUTONOMA DE BARCELONA | Hospital Universitari Vall d'Hebron, Barcelona | IOB Institute of Oncology, Vall d´Hebron Institute of Oncology (VHIO) | Liver Unit, Department of Internal Medicine, Hospital Universitario Vall d´Hebron | Medical Oncology Department, Vall d'Hebron Institute of Oncology, CIBERONC | Multiple Sclerosis Centre of Catalonia (Cemcat), Vall d'Hebron Barcelona Hospital Campus | University Hospital of Vall d'Hebron | Vall de Hebron, Barcelona, Spain | Vall d'Hebron Institut de Recerca (VHIR) | Vall d'Hebron institute of oncology (VHIO), Catalan institute of oncology (Hospitalet) (ICO) | Vall d'Hebron Institute of Research, Galatea Clinic | Vall d'Hebron University Hospital and Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain | Vall d'Hebron University Hospital (HUVH) | VHIO (Vall d'Hebron Institute of Oncology)